Mark Green Mark Green, MD Chief Medical Director & VP, Oncology Insights Summary of Expertise Mark R. Green, MD, is Chief Medical Officer and Vice President of Xcenda's Oncology Insights consulting practice. This team conducts market research to help manufacturers understand how and why medical providers make the choices they do relative to patient treatment. They then analyze the findings and develop strategies to help manufacturers succeed in the evolving value-based oncology market. Dr. Green also leads the Network for Oncology Communication and Research (NOCR), a nationally representative group of more than 3,000 academic, hospital, and community-based oncologists and hematologists as well as more than 1,600 mid-level providers and oncology nurses. A medical oncologist from Charleston, SC, Dr. Green received his undergraduate and medical degrees from Harvard University and did post-graduate training at the Beth Israel Hospital in Boston, the National Cancer Institute, and Stanford University. Between 1976 and 1996, Dr. Green was a member of the faculty at the University of California San Diego School of Medicine, where he held several positions including Director of the UCSD Cancer Center (1986–1990) and the Edwin and Evelyn Tasch Professorship in Cancer Research. Dr. Green joined the faculty of the Medical University of South Carolina in 1996 as the Gilbreth Professor of Clinical Oncology and Director of the Hollings Cancer Center, holding the latter position until June 2000. In January 2005, Dr. Green became a Medical Director for the Network for Medical Communication and Research and a Clinical Professor of Medicine at the Medical University of South Carolina. Dr. Green has been a member of the Cancer and Leukemia Group B since 1976 and served as Chair of the CALGB Respiratory Committee for over 20 years. He served as the vice chairman of CALGB from 1995–2007. He was a member of the American Board of Internal Medicine subspecialty Board of Medical Oncology from 1989–1999 and served as the subspecialty board chair from 1995–1999. His major academic interests are in thoracic oncology, clinical and translational investigation, medical education, and mentoring fellows and young faculty.